RSV

Science

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity — primarily organ transplant recipients…

Read More »
Science

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted…

Read More »
Back to top button